A Study of LY2951742 in Participants With Mild to Moderate Osteoarthritis Knee Pain

NCT02192190 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

268

Enrollment

INDUSTRY

Sponsor class

Stopped Interim assessment: Lack of efficacy

Conditions

Osteoarthritis, Knee

Interventions

DRUG: LY2951742
OTHER: Placebo- oral
OTHER: Placebo - SC
DRUG: Celecoxib

Sponsor

Eli Lilly and Company